The overall actuarial survival rate was 85% at 1 year, 65% at 3 years, and 59% at more than 5 years. The overall actuarial proportion without disease recurrence ... |
Prognosis varies by cancer type, cell differentiation, and stage; firm conclusions are limited by the low incidence of any given tumor. Sarcomas have been the ... |
25 февр. 2020 г. · Regardless of pT or pN, overall 5-years survival for these patients ranges from 10% to 61.4% in the different series. However, the prognosis of ... |
Sarcomas have been the most well-studied chest wall tumors and primary chest wall sarcomas have a reported 5-year survival rate of 17 percent. Chest wall tumor ... |
The cumulative 5-year survival rate was 58% (95% CI, 32–83%) and remained stable up to 10 years (see Fig. 2) . Cumulative survival rates of 22 women with local ... |
31 окт. 2022 г. · According to statistical reports, around 17% of primary chest wall sarcomas are reported to have a 5-year survival rate. However, survival rates ... |
One-year and 5-year overall survival rates were 95.1% and 88.5%, respectively. Histopathologically, tumor infiltration of bone (ribs, scapula, and sternum) was ... |
5 окт. 2019 г. · The 5-year overall survival (OS) rates reported by previous reviews are acceptable [1–9], ranging from 59% to 68%. Many risk factors are known ... |
14 дек. 2017 г. · The median survival time following the diagnosis of metastasis was 0.9 years. In the multivariate analysis, age, tumor size, histological grade ... |
19 июн. 2014 г. · The 3-year survival rate was 65%. Recurrences occurred in 24 patients (60%), 14 developed local recurrences, and 10 developed distant metastases ... |
Novbeti > |
Axtarisha Qayit Anarim.Az Anarim.Az Sayt Rehberliyi ile Elaqe Saytdan Istifade Qaydalari Anarim.Az 2004-2023 |